Delivery Order SPE2DB20D2104-SPE2DB26FMAMS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $50,064.71 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, issued on September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.09 to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packaging) on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price contract, with no set-aside designation, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Latuda 60 mg tablets in quantities of 30 units, with a contract ceiling value of $3,132.62. This firm fixed-price delivery order is non-competitive and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract is scheduled for completion by April 22, 2025, and will be fulfilled from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count packaging) under a firm fixed-price arrangement. The contract, valued at $7,553.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. AmerisourceBergen will perform fulfillment operations from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $28,377.71 by the Defense Logistics Agency to supply Latuda 20 mg tablets (30-count packages). This firm fixed price, competitively awarded contract was issued on June 9, 2025, with an ultimate completion date of June 10, 2025. The pharmaceutical products will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAMSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,694.31 to AmerisourceBergen Drug Corp for the supply of Latuda 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on October 21, 2025, with completion targeted for October 22, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle extending through December 2026 that enables the company to deliver medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across diverse pharmaceutical categories including specialty medications, brand-name and generic drugs, and medical supplies. As a child delivery order under the SPE2DX IDC, this Latuda procurement exemplifies the company's role in fulfilling ongoing medical supply requirements for the department of defense, with the underlying master contract structured to support multiple therapeutic domains and customer agencies through a flexible global procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 10/21/25 |